EASL Members: Request your free copy of the EASL history book
On 20 July 2010, the European Commission Directorate General for Research published the 2011 Health Work Programme of the Seventh Framework Programme for research and technological development (FP7)
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide... Read more
Latest news
2010-08-24
http://ec.europa.eu
Voice your opinion about research funding! This survey addresses the Interim Evaluation of the Seventh Framework Programme for Research and Technological Development (FP7). The Interim Evaluation of FP7 is being carried out by a group of independent experts, supported by an [...] Read more
2010-08-13
EASL Special Conference 25-26 June 2010
Conference newsletterHepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide, and as such represents a significant disease burden.  Under the auspices of the European Association for the Study of the Liver (EASL)  and Chairmanship of EASL [...] Read more
2010-07-28
EASL
On 20 July 2010, the European Commission Directorate General for Research published the 2011 Health Work Programme of the Seventh Framework Programme for research and technological development (FP7)which contains the following calls for proposals in the area of health [...] Read more
2010-07-28
EASL
On 10 June 2010, EASL presented, together with the Chronic Disease Alliance (CDA), a policy paper on chronic diseases to the European Commissioner for Health and Consumer Policy, John Dallì.  The policy paper is developed by the Chronic Disease Alliance with EASL’s contribution [...] Read more
2010-07-16
Parliament Magazine
The Parliament Magazine has recently published an article on the Chronic Disease Alliance meeting with John Dalli. This press release has been disseminated in HealthCanal and posted on the ESC website. Please consult below the links to the different news sources:The Parliament [...] Read more
2010-07-12
European Commission Research
This survey addresses the Interim Evaluation of the Seventh Framework Programme for Research and Technological Development (FP7)The Interim Evaluation of FP7 is being carried out by a group of independent experts, supported by an extensive base of evidence. In order to provide [...] Read more
2010-07-12
IMI - Innovative Medicines Initiative
The Innovative Medicines Initiative welcomed 270 high level industry representatives, regulators, policy makers, top level scientific experts, patient representatives and science leaders at its first Stakeholder Forum in Brussels.The event featured interesting presentations and [...] Read more
2010-07-07
Reference: Cordis News [Date: 2010-06-22]
Commission pushes for more research, less red tapeIn an effort to cut red tape and focus on research results, the European Commission has recently adopted two major initiatives that will see changes to the financial regulations and a simplification of the procedures surrounding [...] Read more
2010-06-29
European Association for the Study of the Liver
Following the successful 2010 EASL Special Conference on 'Hepatocellular Carcinoma, from genomics to treatment' that took place in Dubrovnik, Croatia last week, June 25-27, below is an overview of the press coverage generated by this event.All the websites listed below have [...] Read more
2010-06-25
European Association for the Study of the Liver
As EASL's Special Conference on Hepatocellular Carcinoma 'from Genomics to Treatment' begins, world renowned experts assemble in Dubrovnik, Croatia to discuss the latest trends in treatment and cutting edge research in diagnostic techniques that will shape the future management [...] Read more